VEGFA and age-related macular degeneration: VEGF inhibitors such as bevacizumab (AvastinTM), ranibizumab (LucentisTM) or aflibercept (EyleaTM) have proven to be effective in treating exudative AMD and represent the current mainstay therapeutic treatment [7].